You typically need two treatments, two weeks apart with maintenance sessions every six months. “You will see a quick result in areas such as the under-eyes, but the product will continue to stimulate for 12 weeks, so the result is also a gradual onset," Dr Soni says.
In 2021, the Botulinum Toxin and Cosmetic Fillers (Children) Act was introduced. The act made it a criminal offence to administer injectable toxins or a filler by way of injection for a cosmetic purpose to a person under the age of 18 in England, even if they have the permission of someone over 18.
These fillers are more suited to finer corrections and can provide a more natural feel when injected, such as for less dynamic wrinkles (tear troughs, soft tissue found in lips and the periorbital region). However, these gels tend to have a shorter residence time in the tissues.
We will seek to publish the details of the responses received and our finalised policy positions in a timely way to ensure progress is made on this important work.
The specific criteria that practitioners must meet to be eligible to provide clinical oversight will be determined as part of the next phase of this work when the training and qualifications framework is agreed.
Unlike medicines, medical devices such as dermal fillers have no legal requirement to provide safety and efficacy data, or how they perform in comparison to other market brands.
Data about respondents’ job role, work location, age, sex and gender, qualifications, data on organisations that respondents may be responding on behalf of, and information on any non-surgical cosmetic procedures they have undergone will be used in the analysis of the consultation to help the department understand how people from different groups respond to the consultation’s proposals.
″ across all frequencies), except for the products intended for more superficial tissues, such as under‐eye and tear trough treatment (Teoxane's Redensity II) and superficial lines (Revolax' Fine), in line with their intended target application. Table 2 shows a partial summary of this data, with G
No information regarding Revolax was found in scientific publications, therefore the manufacturers device patent was accessed to provide product information. It was necessary to Order Hyaluronic Acid Fillers for Delivery search for patent information for Teoxane RHA, Restylane OBT, and Juvaderm Vycross technologies to establish the degree of cross linking. This measurement often differs in research literature therefore manufacturers patent application was used to find this value.
There are several voluntary industry associations within the aesthetic industry for non-healthcare professionals. These include the:
This measure is important to understand how a given filler will respond to the injection of hyaluronidase, routinely used in case of occlusions.
The Health and Care Act 2022 included definitions of those procedures considered to have the highest potential to cause harm, while also allowing flexibility for new procedures to be covered through regulations in the future. The drafting of the act is as follows:
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
Further work - including stakeholder engagement and public consultation - will be needed to determine the principles that will underpin the scheme including education and training standards, infection control and cleanliness, indemnity requirements and licensing fees.